Systematic (IUPAC) name | |
---|---|
(1R,2S,10S,11S,13S,14R,15S)-14-(2-chloroacetyl)-1-fluoro-14-hydroxy-2,13,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-diene-5,17-dione | |
Clinical data | |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Pregnancy cat. | ? |
Legal status | ? |
Routes | topical |
Identifiers | |
CAS number | 54063-32-0 |
ATC code | D07AB01 S01BA09 |
PubChem | CID 71387 |
ChemSpider | 64482 |
UNII | LT69WY1J6D |
KEGG | D07717 |
Synonyms | (8S,9R,10S,13S,14S,16S,17R)-17-(2-Chloroacetyl)-9-fluoro-17-hydroxy-10,13,16-trimethyl-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthrene-3,11-dione |
Chemical data | |
Formula | C22H26ClFO4 |
Mol. mass | 408.891 |
SMILES | eMolecules & PubChem |
|
|
(verify) |
(what is this?)
Clobetasone (INN[1]) is a corticosteroid used in dermatology, for treating such skin inflammation as seen in eczema and other forms of dermatitis, and ophthalmology.
It is available as clobetasone butyrate under the brand name Eumovate[2] or Trimovate,[3] both manufactured by GlaxoSmithKline.
As Trimovate, it also contains Oxytetracycline, an antibiotic, and nystatin, an antifungal[4][5].